Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington mouse model and human ALS spinal cord tissue

Haider, Ahmed; Spinelli, Francesco; Müller Herde, Adrienne; Mu, Boshuai; Keller, Claudia; Margelisch, Markus; Weber, Markus; Schibli, Roger; Mu, Linjing; Ametamey, Simon M.

doi:10.1016/j.ejmech.2017.12.097

Metadata only

Author

Haider, Ahmed

Spinelli, Francesco

Müller Herde, Adrienne

Date

2018-02-10

Type

Journal Article

Citations

Cited 20 times in Web of Science

Cited 23 times in Scopus

ETH Bibliography

yes

Altmetrics

Publication status

published

External links

https://doi.org/10.1016/j.ejmech.2017.12.097

Journal / series

European Journal of Medicinal Chemistry

Volume

145

Pages / Article No.

746 - 759

Publisher

Elsevier

Subject

Cannabinoid receptor type 2; Positron emission tomography; Neuroimaging; Chorea Huntington; Amyotrophic lateral sclerosis

Organisational unit

03688 - Schibli, Roger / Schibli, Roger

More

Show all metadata

Citations

Cited 20 times in Web of Science

Cited 23 times in Scopus

ETH Bibliography

yes

Altmetrics

Research Collection

Search

Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington mouse model and human ALS spinal cord tissue Mendeley CSV RIS BibTeX

Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington mouse model and human ALS spinal cord tissue

Mendeley

CSV

RIS

BibTeX